Key result
LBBAP yields comparable LVEF improvement to CRT despite greater QRS narrowing in moderate LV dysfunction.
Why the study?
In patients with LVEF 35–50% requiring ventricular pacing, both CRT and conduction system pacing are viable options, but real-world comparative data on electrical, structural, and clinical outcomes between LBBAP and conventional CRT are scarce.
Does left bundle branch area pacing (LBBAP) improve procedural, electrical, echocardiographic, and clinical outcomes compared to conventional cardiac resynchronization therapy (CRT) in patients with LVEF 35–50% requiring ventricular pacing?
Cohort (n=37)
No
Does left bundle branch area pacing (LBBAP) improve procedural, electrical, echocardiographic, and clinical outcomes compared to conventional cardiac resynchronization therapy (CRT) in patients with LVEF 35–50% requiring ventricular pacing?
In patients with LVEF 35–50% requiring ventricular pacing, LBBAP offers superior electrical resynchronization and comparable structural, clinical, and safety outcomes to conventional CRT, supporting its use as a viable physiological pacing alternative.
LBBAP may offer a physiological alternative in LVEF 35–50%; leaves open randomized confirmation of clinical outcomes.
Introduction In patients with moderately reduced left ventricular ejection fraction (LVEF 35–50%) who require ventricular pacing, right ventricular pacing can induce ventricular dyssynchrony and increase the risk of left ventricular dysfunction. Current expert consensus recognize both CRT and conduction system pacing as viable options. Left bundle branch area pacing (LBBAP) provides a more physiological ventricular activation and may offer advantages over conventional CRT in selected patients, but real-world comparative data on electrical, structural and clinical outcomes are still scarce. Purpose To compare procedural, electrical, echocardiographic and clinical outcomes between LBBAP and CRT in a real-world cohort of patients with bradycardia pacing indication and LVEF 35-50%. Methods A retrospective, single-center study was conducted including 37 patients who underwent either LBBAP (n=20) or CRT (n=17) implantation. Baseline characteristics, procedure metrics and complications were recorded. Electrocardiographic, echocardiographic and clinical parameters were evaluated at baseline and follow-up. Results Baseline clinical parameters were similar between groups. Procedural duration, fluoroscopy time and complication rates were similar. Mean baseline QRS duration was similar (133±32ms for LBBAP and 135±27ms for CRT, p=ns) although LBBAP resulted in greater QRS shortening (–19.3±24.9 ms) compared with CRT (+4.5± 33.3 ms, p=0.033). Mean baseline left ventricular ejection fraction (LVEF) was also similar between groups (39±4% for LBBAP and 37±2% for CRT). Improvements in LVEF were nearly identical (+8.0±8.4% with LBBAP vs +7.7±8.9% with CRT; p=0.920), as were changes in GLS (–0.9±3.6% vs –1.0±1.7%; p=0.969). Left ventricular volumes showed parallel reductions without significant differences between groups. Atrial and diastolic parameters including ΔLAVI, ΔE/e’ and ΔPASP demonstrated variable but comparable patterns. Clinically, no significant differences were observed between strategies and changes in NYHA class were similar and did not reach statistical significance (+0.3±0.8 with LBBAP vs -0.4±0.6 with CRT, p=0.08). Conclusions In patients with LVEF 35–50% requiring ventricular pacing, LBBAP demonstrated a safety profile comparable to CRT and provided markedly superior electrical resynchronization; however, this did not translate into significant differences in structural remodeling or clinical outcomes. These findings support LBBAP as a robust physiological pacing strategy and a viable and cheaper alternative to conventional CRT in everyday practice.
No takes yet. Share an insight, caveat, or question.
Cazeiro et al. (2026) conducted a cohort in Bradycardia pacing indication with moderately reduced left ventricular ejection fraction (LVEF 35-50%) (n=37). Left bundle branch area pacing (LBBAP) vs. Cardiac resynchronization therapy (CRT) was evaluated on Change in left ventricular ejection fraction (LVEF) (p=0.920). LBBAP achieved greater QRS shortening than CRT (–19.3 vs +4.5 ms, p=0.033) with comparable LVEF improvement (+8.0% vs +7.7%, p=0.920) in patients with LVEF 35–50%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: